Equities

Kuangli Bio Tech Holdings Co Ltd

6431:TAI

Kuangli Bio Tech Holdings Co Ltd

Actions
Consumer DiscretionaryPersonal Goods
  • Price (TWD)16.50
  • Today's Change-0.10 / -0.60%
  • Shares traded63.17k
  • 1 Year change+3.13%
  • Beta--
Data delayed at least 20 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kuangli Bio Tech Holdings Co Ltd is a Taiwan-based company principally engaged in the processing of optical glass. The Company's main products include smart phone cover glass, tablet cover glass, mobile phone and tablet camera lens, acrylic material plexiglass and other flat panels, as well as open-molded polymethyl methacrylate (PMMA)/polyethylene glycol terephthalate (PET) decoration products. The Company mainly distributes its products in domestic market and to overseas markets, such as Mainland China and Korea.

  • Revenue in TWD (TTM)333.31m
  • Net income in TWD-147.61m
  • Incorporated2012
  • Employees--
  • Location
    Kuangli Bio Tech Holdings Co LtdNo. 5Chongshan 1st Street, East DistrictTAIPEI 104TaiwanTWN
  • Phone+886 225178779
  • Fax+886 225174559
  • Websitehttp://www.kl-holdings.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Mao Bao INC582.19m8.07m1.20bn198.00148.922.4456.422.060.190.1913.7111.590.91293.566.96--1.272.581.563.2840.9441.211.392.752.55--0.024144.01-5.59-0.3072-217.22--44.62--
Kuangli Bio Tech Holdings Co Ltd333.31m-147.61m1.20bn----2.28--3.61-2.30-2.305.157.270.32164.885.40---14.24-4.69-19.91-6.8817.9416.17-44.29-12.810.7557-9.080.3982---14.2624.00-52.95--192.38--
Luo Lih Fen Holding Co Ltd1.13bn92.73m2.70bn--29.141.5916.552.391.961.9623.8635.960.51746.09205.14--4.457.685.579.2162.2962.568.6016.042.21--0.042674.9912.19-6.4960.97-27.19-3.75-27.21
Maywufa Co Ltd1.45bn172.90m3.04bn282.0017.641.4714.902.101.301.3010.8615.580.49431.915.87--5.915.826.846.9565.3564.6011.9512.781.8042.230.224287.014.472.974.4917.4283.2918.13
Jourdeness Group Ltd2.52bn-212.05m3.19bn----1.665.991.27-3.53-3.5341.9230.980.32182.4516.17---2.712.79-5.015.1263.9372.35-8.427.100.4266-5.890.619473.617.10-0.8693-101.85--5.86-25.90
Farcent Enterprise Co Ltd2.55bn237.96m3.41bn350.0014.321.8010.641.333.763.7640.3929.921.034.355.28--10.7611.9414.2516.6647.4845.1010.4710.513.39--0.001272.42-6.05-2.60-8.85-5.12-54.10-4.36
KNH Enterprise Co Ltd2.87bn-401.64m3.62bn1.04k--1.36--1.26-2.06-2.0614.7013.670.3853.303.24---5.394.19-6.975.607.5217.21-13.997.111.50-8.180.557255.65-12.34-3.63350.85--1.138.45
Maxigen Biotech Inc623.76m155.34m3.89bn96.0025.082.9221.376.241.741.746.9914.980.40562.196.41--10.108.3711.489.7869.7256.2924.9019.503.40--0.0046.822.937.7818.9523.79-1.2011.13
Data as of Nov 22 2024. Currency figures normalised to Kuangli Bio Tech Holdings Co Ltd's reporting currency: Taiwan Dollar TWD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.